NCI To Appoint Expert Group To Consider Standards For Outcomes Measurement.
Carroll Named Deputy Director At Huntsman; Pamer Leads Infectious Disease Service, MSKCC.
Oncology Nursing Society Names 15 To Advisory Panel.
IND-Exempt Trials May Need Special Review, HCFA Says.
NCI To Pilot Text Chat On CancerNet And CIS Sites.
Satcher Calls For Wider Use Of Smoking Prevention Efforts.
NIH Funds 11 New Grants In Women’s Health Research.
FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.
M.D. Anderson, SWOG To Use Web-Based Software To Expand Access To Trials.
Polymer Platinate Begins Testing In Phase I Trial.
Abbott To Supply Quest With Immunoassay Tests.
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ
